PMC:7558914 / 18540-18853 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"444","span":{"begin":38,"end":56},"obj":"Chemical"},{"id":"445","span":{"begin":165,"end":177},"obj":"Chemical"},{"id":"458","span":{"begin":238,"end":247},"obj":"Disease"},{"id":"459","span":{"begin":266,"end":285},"obj":"Disease"}],"attributes":[{"id":"A444","pred":"tao:has_database_id","subj":"444","obj":"MESH:D006886"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"MESH:D017963"},{"id":"A459","pred":"tao:has_database_id","subj":"459","obj":"MESH:D012140"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In our study, monotherapy with 400 mg hydroxychloroquine twice daily the first day followed by 200 mg twice daily from day 2 to day 5, alone and in combination with azithromycin, were the preferred recommended regimens among protocols in Andalusia for treating mild respiratory illness with clinical risk factors."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T32","span":{"begin":266,"end":285},"obj":"Phenotype"}],"attributes":[{"id":"A32","pred":"hp_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/HP_0002086"}],"text":"In our study, monotherapy with 400 mg hydroxychloroquine twice daily the first day followed by 200 mg twice daily from day 2 to day 5, alone and in combination with azithromycin, were the preferred recommended regimens among protocols in Andalusia for treating mild respiratory illness with clinical risk factors."}

{"project":"LitCovid-sentences","denotations":[{"id":"T122","span":{"begin":0,"end":313},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In our study, monotherapy with 400 mg hydroxychloroquine twice daily the first day followed by 200 mg twice daily from day 2 to day 5, alone and in combination with azithromycin, were the preferred recommended regimens among protocols in Andalusia for treating mild respiratory illness with clinical risk factors."}